Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0000891618-04-001006
Filing Date
2004-05-14
Accepted
2004-05-14 17:28:38
Documents
1
Group Members
DANIEL K TURNER IIIHOWARD D PALEFSKYMONTREUX EQUITY MANAGEMENT II SBIC LLC

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 2 TO SCHEDULE 13D f99126a2sc13dza.htm SC 13D/A 114031
  Complete submission text file 0000891618-04-001006.txt   116124
Mailing Address 3260 WHIPPLE ROAD UNION CITY CA 94587-1217
Business Address 3260 WHIPPLE ROAD UNION CITY CA 94587-1217 5104000700
QUESTCOR PHARMACEUTICALS INC (Subject) CIK: 0000891288 (see all company filings)

EIN.: 330476164 | State of Incorp.: CA | Fiscal Year End: 0731
Type: SC 13D/A | Act: 34 | File No.: 005-43062 | Film No.: 04809141
SIC: 2834 Pharmaceutical Preparations

Mailing Address 2500 SAND HILL ROAD SUITE 215 MENLO PARK CA 94025
Business Address
MONTREUX EQUITY PARTNERS II SBIC LP (Filed by) CIK: 0001277894 (see all company filings)

EIN.: 770530710 | State of Incorp.: CA | Fiscal Year End: 1231